CNBC: Investors see growth opportunity in Femtech devoted to women’s health

Santé

CNBC: Investors see growth opportunity in Femtech devoted to women’s health

March 21, 2022

Early-stage investors have been among the biggest backers of health tech companies focused on women’s health conditions.  Venture capital funding for so-called Femtech has tripled since 2015 from just over $600 million to nearly $1.9 billion last year, according to Pitchbook data.

Yet, analysts say overall investment in women’s health remains underfunded. Beyond breast cancer, female health conditions garnered just 1% of pharmaceutical research funding in 2020, according to a McKinsey report. Just 2% of medical tech funding was devoted to non-cancer related women’s conditions.

View full article: https://www.cnbc.com/2022/03/21/investors-see-growth-opportunity-in-femtech-devoted-to-womens-health-.html